STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma

Leukemia. 2021 May;35(5):1500-1505. doi: 10.1038/s41375-020-01093-1. Epub 2020 Nov 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Lymphoma, Large-Cell, Anaplastic / genetics*
  • Lymphoma, Large-Cell, Anaplastic / pathology*
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Prognosis
  • STAT3 Transcription Factor / genetics*
  • Tumor Suppressor Protein p53 / genetics*
  • Young Adult

Substances

  • STAT3 Transcription Factor
  • STAT3 protein, human
  • TP53 protein, human
  • Tumor Suppressor Protein p53

Associated data

  • ClinicalTrials.gov/NCT03199066